This guide answers the most common questions about tirzepatide dosing: how its measured, what the weekly schedule looks like, where you start, how high it goes, and how compounded versions differ
HoZ: Methodology, Project administration, Writing review and editing
Retrieved from Ghaleb, J., Khouzami, K
Evidence boundary No clinical trial has tested retatrutide and MOTS-c as a combination
For this reason, some people prefer the 10 mg/mL concentration at lower doses where precision in the early stages matters most, then switch to 20 mg/mL at higher doses where the volume becomes the bigger concern
There is no click mechanism to dial your dose